Optional product analytics
With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
KLA Corporation's published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $242.5B | |
|---|---|---|
| Revenue (ttm) | 13.6B | |
| Net income (ttm) | 4.8B | |
| EPS (ttm) | $3.66 | |
| Shares out | 1.3B | |
| P/E (trailing) | 43.3x | |
| P/E (forward) | 31.9x | |
| Dividend | $0.92 (0.58%) | |
| Volume | 7,943,102 | |
| Beta | 1.45 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | 2026-06-30 | Trend |
| Revenue | $9.21B | $10.50B | $9.81B | $12.16B | $13.58B | +10.2% |
| Gross profit | $5.62B | $6.28B | $5.88B | $7.40B | $8.32B | +10.3% |
| Operating income | $3.65B | $4.09B | $3.50B | $4.95B | $5.66B | +11.6% |
| Net income | $3.32B | $3.39B | $2.76B | $4.06B | $4.83B | +9.8% |
| EPS (diluted) | $2.19 | $2.42 | $2.03 | $3.04 | $3.66 | +13.7% |
| EBITDA | $4.01B | $4.50B | $3.90B | $5.34B | $5.76B | +9.5% |
| R&D | $1.11B | $1.30B | $1.28B | $1.36B | $1.53B | +8.5% |
| SG&A | $860.0M | $986.3M | $969.5M | $1.03B | $1.13B | +7.1% |
Recent company headlines from major financial publishers.
Better component availability supports growth while FY2026 profitability holds. Weaker annual revenue expectations or sustained margin erosion by FY2028 would disconfirm it.
Core growth and profitability must persist without a large internal capital build. Renewed shipment limits or weaker margins by FY2028 would disconfirm it.
| Ke ↓ / g → | 2.0% | 2.5% | 3.0% | 3.5% | 4.0% |
|---|---|---|---|---|---|
| 8.4% | $126 | $131 | $137 | $143 | $152 |
| 9.4% | $113 | $117 | $120 | $125 | $130 |
| 10.4% | $103 | $106 | $109 | $111 | $115 |
| 11.4% | $95.1 | $96.9 | $98.9 | $101 | $104 |
| 12.4% | $88.4 | $89.7 | $91.2 | $92.9 | $94.7 |
Upcoming earnings date and setup when available.
The rating each month's published research edition carried. A rating compares the price at analysis with the Fair value; it is not a record of whether the call was right.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |